WHO ICTRP trial

A single-center prospective randomized controlled clinical study on the…

ChiCTR2000032553 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2000032553
Public title A single-center prospective randomized controlled clinical study on the prevention of calcium oxalate stone formation by oxalate degrading enzyme combined with vitamin E and B6
Scientific title A single-center prospective randomized controlled clinical study on the prevention of calcium oxalate stone formation by oxalate degrading enzyme combined with vitamin E and B6
Primary sponsor Department of Urology, Wuming Hospital Affiliated to Guangxi Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 0
Countries china
Conditions calcium oxalate urinary stone
Interventions Drug combination group:Combined with oxalic acid degrading enzyme and vitamin B6, vitamin E;Oxalic acid degrading enzyme treatment group:Take oxalate degrading enzyme;Vitamin treatment group:Take vitamins;Blank control group:Nil
Registration date May 2, 2020
Target size Drug combination group:30;Oxalic acid degrading enzyme treatment…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations